<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/news" routerlinkactive="active" class="nav-link" href="/news">News</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">About GARD</a><a routerlink="/espanol" routerlinkactive="active" class="nav-link" href="/espanol">En Espan√µl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 9553 - Post-transplant lymphoproliferative disease</h1></div><div><p><b>Other Names: </b>PTLD, Post-transplant lymphoproliferative disorder</p><p><b>Categories: </b><!----></p><p><b>This disease is grouped under: </b></p><p><b>Summary: </b><span><strong>Post-transplant lymphoproliferative disease</strong>&nbsp;(PTLD) is a complication of transplantation in which there is uncontrolled growth of <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphocyte" target="_blank">lymphocytes</a>.[15256][15257] It occurs in people whose immune systems have been intentionally suppressed due to having a solid organ transplant or <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematopoietic-stem-cell" target="_blank">hematopoietic stem cell</a> transplant.[15256] The severity of PTLD can range from causing a mild, noncancerous (benign) overgrowth of tissue, to causing a life-threatening, cancerous (malignant) form of <a href="https://www.cancer.org/cancer/lymphoma.html" target="_blank">lymphoma</a>.[15258] Common signs and symptoms are often vague, such as feeling unwell (malaise), fever, weight loss, night sweats, fatigue, and swollen lymph nodes.[15257][15258] Additional symptoms depend on the organs or body part(s) affected.[15258] The digestive tract, central nervous system, and/or transplanted organ are often involved.[15258]<br>
<br>
PTLD is often caused by <a href="https://www.cdc.gov/epstein-barr/about-ebv.html" target="_blank">Epstein-Barr virus</a> (EBV), which infects lymphocytes called&nbsp;<a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-cell" target="_blank">B-cells</a>. Most people get EBV in childhood, but the virus becomes "inactive" because the immune system keeps it under control. In people with PTLD due to EBV, a weakened immune system may allow EBV to reactivate in infected B-cells, leading to their uncontrolled growth. In some cases, EBV from the transplant donor is reactivated in the recipient. PTLD can also occur if a recipient first becomes infected with EBV after  the transplant.[15257][15258] The reason that PTLD develops in people without EBV is not clear.[15256]<br>
<br>
PTLD is diagnosed by <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunophenotyping" target="_blank">immunophenotyping</a> a biopsy of an involved lymph node or other affected tissue.[15257] Additional tests such as blood tests, imaging tests, or bone marrow biopsy may be needed to determine the location(s) and extent of the disease in the body.[15257]<br>
<br>
Treatment recommendations may vary among people with PTLD but typically include lowering the dose of immunosuppresive drugs to allow the immune system to fight the EBV-infected cells.[15257] There are no therapies approved by the FDA to treat PTLD, but additional treatment options include using <a href="https://www.cancer.gov/about-cancer/treatment/drugs/rituximab" target="_blank">rituximab</a>, surgery to remove affected tissue, radiation therapy, <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunotherapy" target="_blank">immunotherapy</a>, and&nbsp;chemotherapy. Other treatments are being studied in clinical trials.[15256][15257]</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Leukemia and Lymphoma Society</a></span><br><span>3 International Drive, Suite 200</span><br><span>Rye Brook NY, 10573</span><br><!----><!----></li><li><span><a href="org.url">Lymphoma Action</a></span><br><span>3 Cromwell Court</span><br><span>Aylesbury , HP20 2PB</span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Post-transplant+lymphoproliferative+disease%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Post-transplant lymphoproliferative disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span>The <a href="https://rarediseases.org/rare-diseases/posttransplant-lymphoproliferative-disorders/" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="https://emedicine.medscape.com/article/431364-overview" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=70568" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>The <a href="https://www.lls.org/sites/default/files/National/USA/Pdf/Publications/FS33_PTLD_2018_FINAL.pdf" target="_blank">Leukemia and Lymphoma Society</a> has an information page on Post-transplant lymphoproliferative disease. Click on the link to view this information page.</span></li><li><span>The <a href="https://www.kidney.org/atoz/content/post-transplant-lymphoproliferative-disorder-ptld" target="_blank">National Kidney Foundation</a> offers an information page on Post-transplant lymphoproliferative disease.</span></li><li><span>The <a href="https://monarchinitiative.org/disease/Orphanet:70568" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch‚Äôs tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span><a href="https://panfoundation.org/index.php/en/patients/assistance-programs/myelodysplastic-syndromes" target="_blank">Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;</span></li><li><span><a href="https://lymphoma-action.org.uk/types-lymphoma-lymphoma-and-other-conditions/post-transplant-lymphoproliferative-disorder-ptld" target="_blank">Lymphoma Action</a> provides information about&nbsp;Post-transplant lymphoproliferative disease.</span></li><li><span>Dierickx D, Habermann TM.&nbsp;<a href="https://www.nejm.org/doi/full/10.1056/NEJMra1702693" target="_blank">Post-Transplantation Lymphoproliferative Disorders in Adults</a>.&nbsp;N Engl J Med. 2018 Feb 8;378(6):549-562.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/">NCATS Home</a></div><div class="col"><a href="javascript: void(0)">Site Map</a></div><div class="col"><a href="javascript: void(0)">Browse Glossary A-Z</a></div><div class="col"><a href="javascript: void(0)">Privacy Notice</a></div><div class="col"><a href="javascript: void(0)">Disclaimer</a></div><div class="col"><a href="javascript: void(0)">Accessibility</a></div><div class="col"><a href="javascript: void(0)">FOIA </a></div><div class="col"><a href="javascript: void(0)">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>
<script src="runtime.e227d1a0e31cbccbf8ec.js" defer=""></script><script src="polyfills.1aefc75bf7d5acb269d2.js" defer=""></script><script src="main.f870601fdb5bc988c829.js" defer=""></script>
<script id="ScullyIO-transfer-state"></script><script src="js/custom.js"></script>

</body></html>